Skip Navigation

Phase I Trial of ZEN003694 ZEN-3694 in Combination with Capecitabine in Patients with Solid Tumors

Brief Summary

Type:
Other

Study Type:
Treatment

Phase:
I

ClinicalTrials.gov Identifier:
NCT05803382

Study #:
STUDY00161206

Start Date:
Feb 13, 2025

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT05803382

View Complete Trial Details & Eligibility at ClinicalTrials.gov